The kidney and strategies for the treatment of hypertension
- PMID: 6207726
- DOI: 10.1016/s0002-9343(84)80038-8
The kidney and strategies for the treatment of hypertension
Abstract
Renal compensatory mechanisms are a chief consideration when selecting an antihypertensive agent. The relationships, therefore, between renal blood flow and glomerular filtration rate, sodium handling by the kidney, and release of renin require particular attention. We shall examine therapeutic measures such as beta adrenergic blockers, vasodilators, calcium entry blockers, and converting enzyme inhibitors in light of their effects on renal blood flow.
Similar articles
-
Strategies in antihypertensive therapy: implications of the kidney.Am J Med. 1986 Dec 15;81(6A):15-9. doi: 10.1016/0002-9343(86)90789-8. Am J Med. 1986. PMID: 2879443
-
Vasodilators, antihypertensive therapy, and the kidney.Circulation. 1987 Jun;75(6 Pt 2):V39-42. Circulation. 1987. PMID: 2882875 Review.
-
Vasodilators, antihypertensive therapy and the kidney.Am J Cardiol. 1987 Dec 14;60(17):57I-60I. doi: 10.1016/0002-9149(87)90461-9. Am J Cardiol. 1987. PMID: 3687806
-
The kidney and effective antihypertensive therapy.Am J Cardiol. 1985 Dec 6;56(16):52H-55H. doi: 10.1016/0002-9149(85)90544-2. Am J Cardiol. 1985. PMID: 2866706 Review.
-
Beta-blockers and the kidney.Miner Electrolyte Metab. 1982 Nov;8(5):237-54. Miner Electrolyte Metab. 1982. PMID: 6132329 Review. No abstract available.
Cited by
-
Nitrendipine and the humoral control of sodium homeostasis.Br J Clin Pharmacol. 1990 Oct;30(4):585-92. doi: 10.1111/j.1365-2125.1990.tb03817.x. Br J Clin Pharmacol. 1990. PMID: 2291870 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical